CoChat
Sign Up
Cited by 237

Nicotine Medications for Smoking Cessation

Henningfield, Jack E.·1995·New England Journal of Medicine
DOI 10.1056/nejm199511023331807
Open this paper in CoChat — free account

Abstract

Cigarettes are among the most addicting products known, and the vast majority of people who quit smoking relapse within days.1,2 In the United States, less than 10 percent of the nearly 20 million people who quit smoking for a day remain abstinent one year later.3 Thus, only 2 to 3 percent of smokers become nonsmokers each year.3 Medications that contain nicotine enable health care providers to increase markedly the ability of their patients to achieve and sustain tobacco abstinence. This review summarizes the scientific rationale for nicotine medications, to help clinicians optimize their use.Pathophysiology of Nicotine AddictionClinical . . .

Integrity signals

Registry

Crossref · 10.1056/nejm199511023331807

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Medically approved oral smoking cessation aids such as nicotine gum and nicotine lozenges with a higher nicotine content and which give greater nicotine delivery to users have previously been shown to be more effective in assisting smoking cessation than products with a lower nicotine content, particularly in more heavily dependent smokers.

    “medically approved oral smoking cessation aids such as nicotine gum and nicotine lozenges with a higher nicotine content and which give greater nicotine delivery to users [36] have previously been shown to be more effective in assisting smoking cessation than products with a lower nicotine content, particularly in more heavily dependent smokers [37–40].”

    From A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette (2022) · cites this paper as [37]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Henningfield, J. E.
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
1995-11-02
Volume
333
Issue
18
Pages
1196-1203
ISSN
  • 0028-4793
  • 1533-4406
DOI
10.1056/nejm199511023331807
Cited by
237
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review